This is a non-core endpoint: only basic statistics are computed.
Carcinoma in situ of other and unspecified sites
CD2_INSITU_OTHER_NOS
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
159 |
4. Check minimum number of eventsNone |
159 |
5. Include endpoints |
1296 |
6. Filter based on genotype QC (FinnGen only) |
1257 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D00-D09
- Name in latin
- Carcinoma in situ locis aliis sive non specificatis
Carcinoma in situ of other and unspecified sites
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1257 | 257 | 1000 |
| Unadjusted period prevalence (%) | 0.38 | 0.09 | 0.46 |
| Median age at first event (years) | 71.71 | 68.23 | 72.61 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1296
- Matched controls
- 12960
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
37.3
322.8
205
65
KCD02
NOMESCO Finland
Transurethral resection of bladder
114.9
307.7
821
192
R31
ICD-10 Finland
Unspecified haematuria
11.2
307.7
720
1297
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
88.7
307.7
374
59
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
109.8
307.7
709
141
UKC02
NOMESCO Finland
Cystoscopy
58.5
307.7
1188
2051
ZX136
NOMESCO Finland
Intravesicalis
49.0
307.7
196
47
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
135.0
307.7
808
157
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
159.7
307.7
602
70
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
76.1
307.7
379
70
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
71.2
307.7
515
119
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
9658.0
307.7
829
*
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
27.4
240.5
168
70
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
65.2
164.8
91
15
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
1802.9
163.1
155
*
KCW96
NOMESCO Finland
Other operations on bladder
37.0
148.5
93
27
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
47.2
142.7
84
19
WX320
NOMESCO Finland
Spinalanesthesy
4.1
134.4
613
2339
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
18.3
112.7
92
54
C67
ICD-10 Finland
Malignant neoplasm of bladder
41.5
110.5
67
17
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
+∞
110.0
104
*
UKB02
NOMESCO Finland
Retrograde ureteroscopy
16.2
105.1
91
60
U06
ICPC
Haematuria
7.4
103.6
161
244
8130/2-C67.2
ICD-O-3
Papillary urothelial carcinoma, non-invasive of lateral wall of bladder
1034.5
99.5
96
*
TKC20
NOMESCO Finland
Catheterisation of bladder
4.5
94.3
269
710
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
13.2
92.4
90
73
KH1AD
NOMESCO Finland
CT of urinary organs
6.8
84.2
140
227
XKD00
NOMESCO Finland
Uroflowmetry
3.1
81.9
548
2496
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
4.3
79.5
233
623
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.0
74.9
466
2019
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
21.2
72.7
55
27
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
7.2
70.1
109
164
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
7.4
61.2
92
133
KCB00
NOMESCO Finland
Biopsy of bladder
21.2
59.4
45
22
WX402
NOMESCO Finland
General anaesthesia
2.9
58.6
369
1578
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
8.6
58.2
76
93
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
3.1
55.8
294
1137
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
55.5
483
2422
WX224
NOMESCO Finland
Blockade of obturius nerve
121.3
54.3
58
5
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
21.7
53.4
40
19
N30.0
ICD-10 Finland
Acute cystitis
3.1
50.0
241
881
J01MA02
ATC
ciprofloxacin; systemic
2.4
49.3
686
4190
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
12.1
49.2
50
43
U76
ICPC
Malignant neoplasm of bladder
21.1
48.9
37
18
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
6.9
45.0
71
108
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
7.3
41.4
62
89
ZXC20
NOMESCO Finland
Use of chemical agents
5.2
41.1
87
176
8130/2-C67.6
ICD-O-3
Papillary urothelial carcinoma, non-invasive of ureteric orifice
+∞
36.6
35
*
4CX01, ,
NOMESCO Finland
190.3
35.9
37
*
KCC10
NOMESCO Finland
Cystoprostatectomy
9.1
35.6
44
50
ZXC15
NOMESCO Finland
Use of photodynamic technique
5.7
34.2
65
119
KED22
NOMESCO Finland
Transurethral resection of prostate
2.7
33.2
208
865
KH1DD
NOMESCO Finland
CT urography of urinary organs
36.1
32.9
42
12
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
37.5
31.6
40
11
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
31.6
294
1465
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.4
31.3
261
1240
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
43.4
31.0
38
9
G04BD12
ATC
mirabegron; oral
2.4
30.8
249
1166
ZXE00
NOMESCO Finland
One hour or less
2.0
30.0
558
3596
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
10.9
29.6
32
30
C66
ICD-10 Finland
Malignant neoplasm of ureter
31.7
28.2
37
12
D09.9
ICD-10 Finland
Carcinoma in situ, unspecified
+∞
27.2
26
*
8130/2-C67.4
ICD-O-3
Papillary urothelial carcinoma, non-invasive of posterior wall of bladder
+∞
26.1
25
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
4.4
25.8
66
156
R33
ICD-10 Finland
Retention of urine
2.3
25.7
224
1077
J01EA01
ATC
trimethoprim; systemic
2.1
25.6
317
1752
KDV10
NOMESCO Finland
Internal urethrotomy
4.8
25.4
58
125
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
5.8
24.9
46
82
G04CA02
ATC
tamsulosin; oral
1.8
24.0
606
4220
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.8
23.1
73
202
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
7.4
21.3
31
43
KCD30
NOMESCO Finland
Destruction of tumour of bladder
34.4
21.2
27
8
U07
ICPC
Urine symptom/complaint other
2.6
20.9
132
546
JN4AD
NOMESCO Finland
Body CT examination
2.2
20.9
201
1002
C67.5
ICD-10 Finland
Malignant neoplasm: Bladder neck
78.1
20.7
23
*
N30.9
ICD-10 Finland
Cystitis, unspecified
3.0
20.5
94
329
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
8.3
19.7
26
32
A98
ICPC
Health maint/preventive medicine
2.7
19.1
1209
10838
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
8.2
18.8
25
31
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
28.3
18.8
25
9
JN3AD
NOMESCO Finland
Abdominal CT examination
2.1
18.6
185
933
N02BE01
ATC
paracetamol; systemic, rectal
2.2
17.9
1144
10073
KBV10
NOMESCO Finland
Removal of stent from ureter
6.1
17.8
31
52
UKD02
NOMESCO Finland
Urethroscopy
7.5
17.4
25
34
J01MA12
ATC
levofloxacin; systemic
1.8
16.9
311
1930
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
16.8
499
3535
J01DB01
ATC
cefalexin; oral
1.8
16.0
1023
8770
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
33.8
15.8
20
6
KC1GB
NOMESCO Finland
Cystography with X-ray
4.6
15.7
37
82
WZC00
NOMESCO Finland
Treatment plan or consultation
1.7
15.5
452
3171
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
4.3
15.3
39
92
WZC30
NOMESCO Finland
Teaching
1.8
15.1
240
1418
C67.6
ICD-10 Finland
Malignant neoplasm: Ureteric orifice
+∞
14.6
14
*
D09.1
ICD-10 Finland
Carcinoma in situ: Other and unspecified urinary organs
+∞
14.6
14
*
KBH20
NOMESCO Finland
Replantation of ureter
27.5
14.3
19
7
B02AA02
ATC
tranexamic acid; systemic
2.2
13.9
130
637
8120/2-C67.2
ICD-O-3
Urothelial carcinoma in situ of lateral wall of bladder
+∞
13.6
13
*
C67.3
ICD-10 Finland
Malignant neoplasm: Anterior wall of bladder
34.4
13.5
17
5
G04CA01
ATC
alfuzosin; oral
1.7
13.3
300
1956
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
11.1
13.0
24
22
SPAT1262
SPAT
Handing over of treatment supplies
1.7
12.9
284
1838
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
22.8
12.9
18
8
SPAT1167
SPAT
Insertion of urinary catheter
2.5
12.2
76
312
U29
ICPC
Urinary symptom/complaint other
2.9
12.1
58
208
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
3.1
12.1
50
165
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.8
12.0
218
1337
WX110
NOMESCO Finland
Infiltration anesthesia
1.5
11.9
805
6709
R39.1
ICD-10 Finland
Other difficulties with micturition
2.7
11.8
65
251
SPAT1263
SPAT
Sampling
1.5
11.5
518
3951
D09.3
ICD-10 Finland
Carcinoma in situ: Thyroid and other endocrine glands
+∞
11.5
11
*
8130/2-C67.5
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder neck
+∞
11.5
11
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
2.3
11.4
85
380
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
11.3
489
3695
N21.0
ICD-10 Finland
Calculus in bladder
3.8
11.3
34
91
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
11.2
666
5375
KBD00
NOMESCO Finland
Partial excision of ureter
43.7
10.9
13
*
D09.7
ICD-10 Finland
Carcinoma in situ of other specified sites
+∞
10.4
10
*
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
10.3
179
1079
D30.3
ICD-10 Finland
Benign neoplasm: Bladder
18.9
10.3
15
8
J01CA08
ATC
pivmecillinam; oral
1.6
10.2
262
1753
G04BD08
ATC
solifenacin; oral
2.0
10.2
109
562
KDE20
NOMESCO Finland
Removal of foreign body from urethra
4.2
10.2
27
66
KBB00
NOMESCO Finland
Biopsy of ureter
40.4
10.0
12
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.1
9.7
95
475
U13
ICPC
Bladder symptom/complaint other
2.8
9.6
48
177
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.1
9.5
91
451
8130/2-C67.8
ICD-O-3
Papillary urothelial carcinoma, non-invasive of overlapping lesion of bladder
100.8
9.4
10
*
KCE02
NOMESCO Finland
Transluminal endoscopic extraction of calculus from bladder
3.8
9.4
28
75
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.4
9.3
61
257
TKC22
NOMESCO Finland
Catheterisation instruction
2.5
9.2
58
240
A02BC02
ATC
pantoprazole; systemic
1.5
9.2
843
7269
U01
ICPC
Dysuria/painful urination
2.2
8.9
76
359
U05
ICPC
Urination problems other
2.0
8.9
91
461
Z3231
NOMESCO Finland
Registered nurse
1.5
8.9
351
2576
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
8.9
302
2150
TKD00
NOMESCO Finland
Dilatation of urethra
4.4
8.9
22
51
B01AB10
ATC
tinzaparin; parenteral
1.8
8.8
136
791
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
8.8
184
1166
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
2.5
8.8
55
227
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.5
8.7
393
2966
JN4CD
NOMESCO Finland
Very extensive body CT
2.2
8.6
69
318
P17
ICPC
Tobacco abuse
4.4
8.6
21
48
WX702
NOMESCO Finland
Supraglottic ventilation device
2.2
8.5
72
340
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.4
8.3
577
4697
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.3
8.3
60
265
N40
ICD-10 Finland
Hyperplasia of prostate
1.4
8.1
510
4080
N35.9
ICD-10 Finland
Urethral stricture, unspecified
3.1
8.0
32
104
KA3EB
NOMESCO Finland
Antegrade pyelography
6.1
7.9
20
33
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
3.3
7.8
29
90
KCV22
NOMESCO Finland
Transluminal endoscopic evacuation of blood clots from bladder
8.5
7.8
16
19
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
4.2
7.7
20
48
JN4BD
NOMESCO Finland
Extensive body CT
1.7
7.7
162
1028
KGH10
NOMESCO Finland
Operation for phimosis
2.3
7.5
54
239
C61
ICD-10 Finland
Malignant neoplasm of prostate
1.5
7.4
226
1566
S18
ICPC
Laceration/cut
1.4
7.3
593
4920
SPAT1312
SPAT
General health counselling
1.4
7.0
355
2716
TJF80
NOMESCO Finland
Ostomy education
3.7
6.9
21
57
XQ848
NOMESCO Finland
Dermatological photography
2.4
6.8
46
198
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
6.1
6.8
17
28
KCW98
NOMESCO Finland
Other transluminal endoscopic operation on bladder
16.8
6.7
10
6
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
3.9
6.7
19
49
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
6.7
731
6323
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
6.6
344
2641
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
1.7
6.6
117
710
U70
ICPC
Pyelonephritis/pyelitis
3.3
6.6
24
74
K02.1
ICD-10 Finland
Caries of dentine
1.4
6.5
581
4864
U71
ICPC
Cystitis/urinary infection other
2.2
6.5
55
261
B01AB05
ATC
enoxaparin; parenteral
1.4
6.4
401
3173
XX3DW
NOMESCO Finland
Time consuming IT work
1.6
6.4
149
970
U02
ICPC
Urinary frequency/urgency
1.6
6.4
140
899
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.9
6.3
76
409
KAC20
NOMESCO Finland
Nephroureterectomy
11.1
6.3
11
10
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
1.5
6.3
208
1465
N02
ICD-10 Finland
Recurrent and persistent haematuria
18.1
6.3
9
5
D09
ICD-10 Finland
Carcinoma in situ of other and unspecified sites
+∞
6.3
6
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.6
6.2
149
976
SPAT1260
SPAT
Consultation of another employee
1.5
6.2
215
1527
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
6.2
108
652
K03.65
ICD-10 Finland
Deposits [accretions] on teeth betel
1.5
6.2
200
1401
N07BA03
ATC
varenicline; oral
2.3
6.1
45
201
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
6.1
459
3734
G04CB01
ATC
finasteride; oral
1.4
6.1
258
1906
T90
ICPC
Diabetes non-insulin dependent
1.4
6.1
343
2665
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
6.1
517
4287
H02.1
ICD-10 Finland
Ectropion of eyelid
3.2
6.0
23
73
KBV00
NOMESCO Finland
Insertion of stent into ureter
5.2
6.0
17
33
KBE12
NOMESCO Finland
Transluminal endoscopic extraction of calculus of ureter
3.3
6.0
22
68
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
1001
4415
6.57
203.59
9.6
3.4
—
—
—
0
0
675
2621
4.29
147.22
6.3
2.7
3.63
3.48
e6/l
0.18
635
2377
822
3710
4.32
144.04
10.7
3.5
383.92
99.97
e6/l
1.43
731
2981
760
3360
4.05
134.41
9.9
3.4
0.19
0.50
e6/l
8.29
679
2659
846
4123
4.03
127.34
11.8
3.9
137.28
118.63
e6/l
0.20
759
3138
1155
7187
6.58
120.61
13.6
4.6
27.00
1742.63
e6/l
1.20
27
130
502
2105
3.26
87.69
9.4
2.9
0.96
1.02
e6/l
0.18
403
1293
478
1986
3.23
84.23
10.3
3.2
1.08
1.20
e6/l
0.25
379
1182
870
5160
3.09
79.34
3.4
2.9
—
—
—
0
0
831
5070
2.78
67.03
8.2
5.0
0.00
0.00
estimate
-0.00
219
989
835
5123
2.77
66.32
6.2
3.8
0.00
0.00
estimate
0.35
236
1059
833
5161
2.72
63.89
6.3
3.8
0.00
0.00
estimate
-0.00
204
945
219
732
3.40
52.90
7.9
2.8
0.14
0.31
e6/l
2.93
219
722
956
6850
2.51
46.23
5.6
5.3
6.87
6.93
mmol/l
0.39
928
6485
836
6097
2.05
32.25
20.7
19.6
1.33
1.40
inr
1.27
282
1733
1197
10169
3.32
31.56
22.9
18.1
29.94
28.79
mg/l
0.52
1043
8352
598
3948
1.96
29.96
6.9
4.1
—
—
—
0
0
1146
9648
2.62
28.18
24.8
17.0
71.54
73.81
ml/min/173m2
3.32
1040
8068
1229
10815
3.64
26.23
28.5
21.5
139.56
139.63
mmol/l
0.42
1210
10541
1229
10833
3.60
25.77
28.9
21.8
4.03
4.02
mmol/l
0.52
1209
10547
1221
10800
3.26
23.84
30.1
21.6
92.04
88.08
umol/l
2.45
1221
10794
878
6862
1.87
23.56
5.7
5.5
2.62
4.01
ug/l
1.39
789
6089
1020
8398
2.01
23.03
9.0
8.2
79.71
81.07
u/l
0.42
970
7882
1235
11056
3.49
22.38
35.1
26.4
235.91
233.09
e9/l
0.86
1207
10725
1235
11056
3.49
22.38
35.2
26.6
39.80
39.89
%
0.19
1148
10170
1235
11058
3.48
22.33
35.2
26.4
7.22
6.95
e9/l
4.09
1205
10673
1235
11058
3.48
22.33
35.2
26.4
4.43
4.45
e12/l
0.49
1205
10674
1235
11060
3.48
22.28
35.4
26.6
133.04
134.97
g/l
3.83
1219
10848
439
2901
1.78
19.76
6.8
4.1
0.00
0.00
estimate
0.50
196
915
765
5919
1.71
19.28
7.1
6.7
10.98
12.68
umol/l
5.25
735
5640
424
2795
1.77
19.12
3.0
2.7
—
—
—
0
0
1200
10769
2.54
18.03
12.8
11.6
25.79
26.44
u/l
0.61
1155
10313
752
5855
1.68
17.92
7.7
7.6
1.21
1.21
mmol/l
0.52
639
4957
931
7723
1.73
17.01
4.3
4.2
15.67
13.93
mm/h
2.08
832
7043
668
5096
1.64
16.79
5.9
5.2
34.29
34.55
g/l
0.57
625
4733
768
6082
1.64
16.51
9.5
9.2
4.57
4.39
e9/l
1.16
665
5307
419
2856
1.69
16.22
4.7
4.2
84.27
82.10
%
0.95
413
2794
655
5053
1.60
15.12
6.1
6.2
24.48
25.71
%
1.91
618
4723
646
4969
1.60
15.09
5.9
6.0
59.86
58.64
%
1.69
611
4645
226
1317
1.87
14.88
4.8
3.8
—
—
—
0
0
624
4795
1.58
14.40
2.5
2.2
—
—
—
0
0
987
8517
1.67
13.43
29.3
21.2
15.26
15.55
%
0.85
974
8351
674
5359
1.54
12.78
6.8
6.6
1.21
1.20
mmol/l
0.47
611
4862
325
2188
1.65
12.68
2.0
1.9
—
—
—
0
0
592
4603
1.53
12.28
13.9
10.7
0.00
0.00
e9/l
0.08
490
3775
474
3526
1.54
11.98
3.0
2.7
61.39
81.11
u/l
0.39
444
3262
156
869
1.90
11.68
4.4
3.8
1.21
1.85
mmol/l
1.33
121
631
1114
10042
1.78
11.64
5.7
5.1
6.25
6.15
mmol/l
1.45
975
8959
164
930
1.87
11.62
4.6
3.8
5.09
5.11
kpa
0.07
159
881
1106
9951
1.76
11.61
5.0
4.9
4.23
4.33
mmol/l
2.27
976
9046
684
5539
1.50
11.34
5.0
4.8
20.83
21.77
%
0.96
383
2947
152
850
1.89
11.24
1.9
1.7
—
—
—
0
0
1024
9066
1.62
11.00
4.8
4.3
1.98
2.05
mu/l
0.86
885
8052
427
3160
1.52
10.80
2.5
2.2
3.16
3.08
mg/l
0.28
358
2688
1124
10215
1.76
10.66
5.6
5.5
2.44
2.51
mmol/l
1.87
989
9214
1091
9857
1.68
10.30
5.0
4.8
1.32
1.37
mmol/l
4.32
954
8875
491
3774
1.48
10.21
3.4
3.4
387.70
294.54
mg/l
0.19
351
2577
512
3984
1.47
9.93
4.0
4.0
9.92
9.40
mg/mmol
0.08
354
2658
534
4196
1.46
9.82
3.2
2.9
159.88
176.50
ug/l
0.82
474
3798
492
3808
1.47
9.77
3.3
3.3
7.50
7.76
mmol/l
0.75
389
3151
502
3907
1.46
9.66
3.3
3.3
0.73
0.80
ug/l
1.19
379
2820
830
7163
1.44
8.81
3.9
3.4
15.02
15.03
pmol/l
0.06
707
6304
207
1359
1.62
8.64
3.7
4.2
22.79
30.47
ug/l
0.22
175
1153
1054
9559
1.55
8.50
4.5
4.3
1.35
1.28
mmol/l
2.73
911
8546
32
101
3.22
8.39
1.5
1.4
—
—
—
0
0
265
1858
1.54
8.31
2.9
2.7
2.31
2.23
g/l
1.40
240
1728
400
3049
1.45
8.30
1.6
1.6
18.92
19.56
nmol/l
0.39
332
2590
1071
9779
1.55
8.05
7.6
6.6
41.90
41.13
mmol/mol
1.78
964
8909
253
1781
1.52
7.75
3.0
2.8
19.35
22.80
%
3.76
213
1518
94
518
1.88
7.28
3.4
2.7
—
—
—
0
0
66
325
2.09
7.04
1.5
1.5
—
—
—
0
0
596
4981
1.36
6.90
2.2
2.1
91.31
91.73
pmol/l
0.08
333
2735
497
4038
1.37
6.86
3.3
3.2
2254.20
1864.23
ng/l
0.53
442
3566
91
512
1.84
6.62
2.0
1.8
—
—
—
0
0
216
1520
1.51
6.56
1.8
1.9
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
93
531
1.81
6.46
3.9
2.7
0.32
0.34
u/ml
0.30
53
305
271
2001
1.45
6.45
3.0
2.7
11.36
12.46
umol/l
1.56
251
1872
715
6184
1.35
6.45
3.2
3.3
55.05
60.62
u/l
0.81
655
5656
212
1514
1.48
5.96
1.8
1.9
—
—
—
0
0
58
292
2.03
5.88
2.3
2.4
122.64
129.31
g/l
0.87
44
220
58
294
2.02
5.77
2.6
2.7
14.94
15.80
%
0.74
34
155
122
779
1.62
5.67
1.6
1.5
—
—
—
0
0
454
3761
1.32
5.15
4.2
3.5
2.34
2.34
mmol/l
0.17
386
3248
145
987
1.53
5.13
4.1
4.4
1.22
1.22
mmol/l
0.18
122
864
92
561
1.69
5.12
2.3
2.0
—
—
—
0
0
555
4736
1.30
5.03
5.2
4.2
44.35
65.43
ng/l
1.09
469
3740
40
186
2.19
5.01
1.3
1.3
9.48
7.71
u/l
0.56
33
143
164
1154
1.48
4.95
2.0
2.3
0.21
0.20
g/l
0.86
150
1061
130
871
1.55
4.95
8.0
9.0
0.51
0.67
%
5.34
130
862
29
119
2.47
4.82
1.5
1.4
—
—
—
0
0
130
879
1.53
4.75
7.8
8.9
1.22
1.35
%
0.92
130
871
176
1268
1.45
4.71
6.7
7.8
10.67
11.22
mmol/l
0.51
166
1202
281
2206
1.35
4.53
1.7
1.7
1.55
1.49
mg/l
0.10
223
1750
222
1686
1.38
4.40
6.4
6.5
1.02
1.02
mmol/l
0.14
210
1566
289
2301
1.33
4.21
7.5
4.2
1.02
1.02
kg/l
0.18
44
340
14
34
4.15
4.21
2.1
1.9
2.16
7.19
nmol/l
0.42
14
28
471
4003
1.28
4.21
2.2
2.2
78.18
77.61
nmol/l
0.16
401
3465
175
1292
1.41
4.10
4.2
3.8
1.38
2.01
mmol/l
1.51
143
1068
25
105
2.41
3.99
1.2
1.2
—
—
—
0
0
301
2428
1.31
3.98
4.4
4.2
453.13
370.65
ng/l
0.15
262
2122
209
1608
1.36
3.81
6.7
7.6
0.27
1.09
mmol/l
2.54
171
1246
75
473
1.62
3.74
4.4
3.5
65.29
8855.76
u/ml
0.84
66
394
208
1607
1.35
3.69
6.7
7.6
5.07
5.08
kpa
0.06
201
1528
208
1608
1.35
3.68
6.7
7.6
12.18
11.75
kpa
0.63
200
1529
172
1291
1.38
3.66
4.3
3.8
5.74
5.84
kpa
0.71
167
1255
172
1291
1.38
3.66
2.7
2.8
8.31
10.48
umol/l
0.42
155
1154
42
226
1.89
3.63
1.8
2.0
1.69
1.75
mmol/l
0.16
42
220
204
1577
1.35
3.61
3.3
4.2
227.18
250.63
u/l
1.90
195
1483
214
1669
1.34
3.57
2.8
2.5
1.74
1.80
%
0.37
194
1484
425
3626
1.26
3.55
2.5
2.2
256.10
240.59
u/l
0.08
394
3387
43
242
1.80
3.26
1.2
1.3
—
—
—
0
0
137
1012
1.40
3.22
2.7
2.4
36.85
35.58
u/l
0.08
120
870
58
357
1.65
3.21
2.2
2.3
204.53
110.82
ug/min
0.31
32
220
60
373
1.64
3.20
1.7
1.7
—
—
—
0
0
123
895
1.41
3.15
3.4
2.2
352.80
368.54
nmol/l
0.33
117
814
34
184
1.87
2.94
1.8
2.0
89.46
89.12
%
0.14
34
184
388
3341
1.23
2.88
3.0
3.3
46.44
40.48
u/l
0.25
362
3169
128
960
1.37
2.77
3.0
3.1
56.90
60.27
ml/min/173m2
0.44
51
410
369
3175
1.23
2.75
3.2
3.1
7865.79
6806.09
umol/l
0.12
299
2716
7
14
5.02
2.73
1.3
1.1
—
—
—
0
0
21
99
2.14
2.65
2.7
1.8
1.11
1.68
u/field
—
9
34
311
2643
1.23
2.59
1.9
1.8
421.47
13982886.27
pmol/l
1.21
236
2167
19
87
2.20
2.58
1.2
1.3
25.43
23.25
iu/l
0.12
14
76
266
2224
1.25
2.57
4.0
3.2
2.47
2.45
mmol/l
1.39
238
1943
240
1991
1.25
2.49
3.8
3.4
0.81
0.82
mmol/l
0.20
223
1867
161
1273
1.30
2.45
2.3
2.7
61.68
68.86
e9/l
1.93
133
996
12
45
2.68
2.45
1.4
1.3
21.40
23.49
u/l
0.10
12
34
17
78
2.20
2.31
1.2
1.4
—
—
—
0
0
296
2535
1.22
2.27
1.8
1.8
1113.34
1159.68
nmol/l
0.37
209
1916
0
61
0.00
2.24
0.0
1.0
—
—
—
0
0
119
915
1.33
2.23
1.6
1.6
—
—
—
0
0
13
54
2.42
2.20
1.0
1.0
—
—
—
0
0
62
427
1.47
2.20
2.8
3.5
4.30
4.33
pmol/l
0.10
57
367
34
203
1.69
2.19
1.1
1.1
—
—
—
0
0
66
464
1.45
2.12
1.3
1.4
—
—
—
0
0
38
237
1.62
2.09
3.7
3.9
1.23
1.37
%
0.12
30
211
317
2755
1.20
2.08
1.6
1.7
1.43
1.32
mmol/l
1.22
247
2250
9
32
2.82
2.00
1.3
1.4
—
—
—
0
0
133
1061
1.28
1.93
3.9
3.0
4.27
4.52
kpa
0.85
128
1030
24
136
1.78
1.88
4.4
2.8
—
—
—
0
0
42
278
1.53
1.83
1.3
1.4
—
—
—
0
0
42
278
1.53
1.83
1.3
1.4
—
—
—
0
0
87
663
1.33
1.77
1.9
1.9
1.02
2.55
ug/l
1.02
78
584
25
149
1.69
1.67
1.7
1.6
303.32
286.30
mu/l
0.07
25
138
90
706
1.30
1.53
1.6
1.8
1.73
1.51
g/l
1.41
83
602
5
16
3.13
1.44
1.4
1.1
364.56
81.14
ng/l
—
5
10
26
165
1.59
1.41
3.0
2.2
1935.27
273.63
u/ml
0.48
26
158
12
60
2.01
1.38
3.3
3.1
243.50
216.47
u/l
0.26
12
60
190
1638
1.19
1.38
1.5
1.5
3.02
2.92
g/l
0.14
118
962
6
23
2.62
1.37
1.5
1.1
—
—
—
0
0
24
153
1.58
1.29
1.2
1.1
1.00
32.47
iu/ml
—
6
30
10
48
2.09
1.28
2.1
1.6
—
—
—
0
0
9
44
2.05
1.27
2.3
2.8
—
—
—
0
0
9
44
2.05
1.27
2.3
2.8
—
—
—
0
0
112
927
1.23
1.25
1.3
1.3
—
—
—
0
0
19
115
1.66
1.25
1.5
2.5
861.71
631.76
ml
—
7
76
13
70
1.87
1.24
1.2
1.4
2.02
1.14
promille
—
8
55
81
648
1.27
1.22
3.3
2.6
1.39
1.13
%
1.05
81
643
167
1440
1.18
1.22
5.0
4.9
33.20
32.45
%
0.39
106
954
5
19
2.64
1.21
2.6
2.6
—
—
—
0
0
5
19
2.64
1.21
2.6
2.6
—
—
—
0
0
13
71
1.84
1.19
1.2
1.7
—
—
—
0
0
13
71
1.84
1.19
1.2
1.7
—
—
—
0
0
23
149
1.55
1.17
1.7
1.8
—
—
—
0
0
15
87
1.73
1.15
1.1
1.6
—
—
—
0
0
12
65
1.85
1.13
4.7
3.6
83.50
82.45
nmol/l
0.03
12
65
42
311
1.36
1.11
1.4
1.5
228.18
252.93
ug/g
0.34
22
195
23
153
1.51
1.06
3.1
4.0
61.23
57.45
%
0.31
16
130
23
153
1.51
1.06
4.2
3.9
—
—
—
0
0
7
33
2.13
1.05
1.4
1.3
—
—
—
0
0
6
121
0.49
1.05
1.8
1.8
—
—
—
0
0
6
121
0.49
1.05
1.8
1.8
—
—
—
0
0
6
121
0.49
1.05
1.8
1.8
—
—
—
0
0
17
106
1.61
1.03
2.2
1.8
—
—
—
0
0
38
281
1.36
1.03
2.5
2.3
212.16
207.16
%
0.12
38
263
11
60
1.84
1.03
1.0
1.3
—
—
—
0
0
18
114
1.59
1.03
2.1
1.2
—
—
u/ml
—
0
0
195
1729
1.15
1.02
1.2
1.2
1.74
1.55
u/ml
0.09
40
432
12
68
1.77
1.00
1.0
1.1
0.31
1.66
u/ml
—
5
34
7
132
0.53
0.99
1.7
1.9
—
—
—
0
0
17
108
1.58
0.96
1.3
1.7
—
—
—
0
0
12
69
1.75
0.96
3.1
3.6
—
—
—
0
0
77
633
1.23
0.96
3.3
2.6
0.66
0.65
%
0.16
77
628
27
191
1.42
0.95
1.4
1.5
27727.29
100414.32
e6/l
1.20
17
116
60
484
1.25
0.90
4.1
3.5
53.12
70.63
mg/l
0.58
45
391
60
484
1.25
0.90
4.1
3.5
76.57
82.02
mg/l
0.05
45
394
36
273
1.33
0.86
1.6
1.6
—
—
—
0
0
18
120
1.51
0.85
1.2
1.4
15.17
13.75
u/l
0.18
18
113
12
72
1.67
0.85
1.9
1.6
95.08
96.83
umol/l
0.07
12
72
58
471
1.24
0.83
4.1
3.5
1.07
1.86
ratio
—
6
39
40
310
1.30
0.83
2.5
2.1
81.55
86.51
%
0.70
40
300
31
232
1.34
0.81
1.1
1.3
—
—
—
0
0
38
294
1.30
0.80
1.6
1.6
1.39
22.10
iu/ml
—
9
61
21
147
1.44
0.80
1.5
1.5
58.92
65.32
%
0.27
12
95
66
548
1.22
0.78
3.3
2.6
—
—
—
0
0
66
548
1.22
0.78
3.3
2.6
7.53
7.33
g/l
0.34
56
495
66
548
1.22
0.78
3.3
2.6
3.78
3.66
g/l
0.23
56
495
18
123
1.47
0.77
1.2
1.3
12.67
12.93
u/l
0.03
18
116
25
184
1.37
0.74
1.5
1.6
—
—
—
0
0
49
397
1.24
0.74
1.1
1.3
—
—
—
0
0
30
228
1.32
0.73
1.5
1.6
—
—
—
0
0
46
373
1.24
0.70
1.2
1.6
—
—
—
0
0
34
266
1.29
0.69
4.7
3.9
28.78
31.93
mg/l
0.20
20
172
12
77
1.56
0.68
1.1
1.1
—
—
—
0
0
25
187
1.34
0.68
1.3
1.3
—
20.36
—
0
5
17
237
0.71
0.66
1.3
1.2
3.98
3.95
mmol/l
0.05
17
216
131
1172
1.13
0.65
2.7
2.7
66.42
66.17
g/l
0.15
119
1071
15
103
1.46
0.65
1.3
1.2
1.20
1.48
nmol/l
0.62
15
94
25
189
1.33
0.64
1.3
1.3
—
—
—
0
0
61
515
1.19
0.64
3.4
2.7
9.86
10.68
g/l
0.94
51
461
122
1088
1.13
0.64
2.2
2.2
10.34
12.51
nmol/l
2.68
104
939
60
507
1.19
0.63
3.5
2.7
3.14
2.98
g/l
0.49
50
455
49
406
1.22
0.63
1.1
1.1
145.67
145.20
iu/ml
—
10
140
100
884
1.14
0.61
4.5
4.3
104.87
102.06
ng/l
0.10
83
773
9
139
0.65
0.60
1.7
1.9
—
—
—
0
0
13
88
1.48
0.60
1.4
1.3
—
—
—
0
0
21
157
1.34
0.59
1.3
1.4
98.86
135.10
u/ml
—
7
25
52
437
1.20
0.59
1.3
1.7
38.62
38.16
u/l
0.07
42
377
140
1270
1.11
0.57
2.9
2.5
6.30
7.12
ug/l
0.26
124
1129
8
55
1.46
0.56
1.0
1.1
—
—
—
0
0
10
65
1.54
0.55
2.5
1.8
—
—
—
0
0
18
239
0.75
0.54
1.9
1.3
908.46
800.44
e6/l
0.04
13
195
18
239
0.75
0.54
1.8
1.3
15.67
42.43
e6/l
0.51
12
188
9
60
1.50
0.54
1.6
1.4
—
—
—
0
0
21
272
0.77
0.54
1.3
1.2
741.24
559.78
mg/l
0.50
21
252
22
171
1.29
0.50
1.1
1.2
328.11
312.28
u/ml
—
9
92
23
180
1.28
0.50
1.1
1.2
—
—
—
0
0
13
93
1.40
0.48
1.0
1.0
—
—
—
0
0
134
1229
1.10
0.47
3.5
3.1
285.02
242.16
ng/l
0.48
124
1125
7
48
1.46
0.47
5.6
4.8
13.41
13.48
%
—
7
48
26
209
1.25
0.46
1.5
1.5
1537.20
1651.20
e6/l
0.08
20
148
30
246
1.22
0.45
1.2
1.4
—
—
—
0
0
14
104
1.35
0.43
1.1
1.1
—
16.46
—
0
5
5
33
1.52
0.41
1.0
1.1
—
24.80
u/ml
—
0
5
30
251
1.20
0.39
1.1
1.2
45.12
62.71
u/l
0.29
30
219
20
248
0.80
0.39
7.7
6.4
609.60
869.15
iu/ml
—
5
40
24
196
1.23
0.39
1.1
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
53
467
1.14
0.38
3.9
2.7
1.75
1.38
g/l
0.23
41
404
9
68
1.33
0.37
1.1
1.1
—
—
—
0
0
9
68
1.33
0.37
1.1
1.1
—
—
—
0
0
18
224
0.80
0.37
2.1
1.8
—
—
—
0
0
18
224
0.80
0.37
2.1
1.8
—
—
—
0
0
9
70
1.29
0.36
1.1
1.1
—
—
—
0
0
9
70
1.29
0.36
1.1
1.1
—
—
—
0
0
9
70
1.29
0.36
1.1
1.1
—
—
—
0
0
6
44
1.37
0.34
1.3
1.3
51.00
24.74
%
—
6
31
33
284
1.17
0.33
1.5
1.5
—
—
—
0
0
6
47
1.28
0.32
1.0
1.6
1628.83
1466.53
u/ml
—
6
47
22
184
1.20
0.30
1.2
1.5
—
—
—
0
0
36
315
1.15
0.30
1.5
1.6
—
—
—
0
0
40
452
0.88
0.30
1.9
1.8
—
—
—
0
0
31
268
1.16
0.30
1.5
1.7
9.35
12.24
mg/l
0.89
25
243
8
62
1.29
0.28
1.5
1.5
—
—
—
0
0
8
62
1.29
0.28
1.5
1.5
—
—
—
0
0
17
140
1.22
0.27
1.3
1.5
—
—
—
0
0
17
141
1.21
0.26
1.3
1.5
—
—
—
0
0
22
188
1.17
0.25
1.7
1.7
—
—
—
0
0
17
142
1.20
0.24
1.3
1.5
—
—
—
0
0
11
137
0.80
0.24
1.8
2.3
—
—
—
0
0
10
78
1.28
0.24
1.6
2.2
—
—
—
0
0
37
332
1.12
0.23
1.3
1.4
—
—
—
0
0
35
313
1.12
0.23
2.9
3.2
0.81
0.82
nmol/l
0.03
29
245
11
88
1.25
0.22
1.0
1.4
—
197.78
—
0
9
5
40
1.25
0.22
1.0
1.3
5.84
25.61
umol/l
—
5
26
10
79
1.27
0.22
1.4
1.5
—
—
—
0
0
10
79
1.27
0.22
1.4
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
20.09
—
0
11
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
14
0.00
0.20
0.0
1.3
—
4744.44
—
0
9
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
3.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
131
1371
0.95
0.20
1.2
1.2
4.90
14.16
u/ml
2.11
37
492
13
155
0.84
0.20
2.1
1.6
—
—
—
0
0
13
155
0.84
0.20
2.1
1.6
—
—
—
0
0
9
112
0.80
0.20
1.1
1.1
—
—
—
0
0
20
174
1.15
0.19
1.4
1.2
—
—
—
0
0
19
165
1.15
0.19
1.5
1.5
7.22
6.57
mmol/l
0.59
19
156
56
523
1.07
0.17
4.2
3.9
1.34
1.41
mmol/l
0.24
56
513
8
70
1.14
0.16
2.5
2.5
—
—
—
0
0
23
206
1.12
0.16
1.3
1.5
—
—
—
0
0
13
111
1.17
0.15
1.2
1.3
14.71
25.35
%
—
7
72
9
80
1.13
0.15
8.1
3.5
—
—
—
0
0
17
192
0.88
0.14
1.2
1.1
—
—
—
0
0
9
83
1.08
0.14
2.3
2.3
—
—
—
0
0
7
86
0.81
0.14
1.0
1.2
99.86
95.60
%
—
7
81
18
160
1.13
0.14
1.1
1.1
1.45
1.60
g/l
0.99
18
145
12
103
1.17
0.13
1.1
1.1
—
—
—
0
0
9
110
0.82
0.13
1.0
1.0
—
—
—
0
0
16
142
1.13
0.12
1.3
1.5
—
—
—
0
0
16
142
1.13
0.12
1.3
1.5
—
—
—
0
0
16
143
1.12
0.11
1.3
1.5
—
—
—
0
0
146
1421
1.03
0.11
1.2
1.3
29.65
43.60
iu/ml
0.69
41
436
45
426
1.06
0.11
3.5
2.5
36.67
37.24
g/l
0.24
35
374
19
173
1.10
0.10
1.7
2.5
13.20
20.18
mg/l
—
5
38
5
45
1.11
0.09
1.2
1.1
—
—
—
0
0
35
330
1.06
0.09
1.7
1.7
—
—
—
0
0
145
1484
0.97
0.09
8.2
8.4
—
—
—
0
0
33
312
1.06
0.08
1.7
1.8
—
—
—
0
0
5
65
0.77
0.08
1.0
1.2
—
—
—
0
0
23
246
0.93
0.08
1.2
1.2
—
4.51
—
0
7
24
256
0.94
0.08
1.6
1.6
—
—
—
0
0
6
70
0.86
0.07
1.8
2.0
—
—
—
0
0
6
70
0.86
0.07
1.8
2.0
—
—
—
0
0
6
72
0.83
0.07
1.2
1.3
—
—
—
0
0
6
72
0.83
0.07
1.2
1.3
—
—
—
0
0
8
77
1.04
0.07
1.3
1.1
2.27
2.05
mmol/l
—
8
71
7
81
0.86
0.07
1.0
1.2
—
—
—
0
0
7
83
0.84
0.07
1.0
1.0
318.14
283.12
mg/l
—
7
73
9
87
1.03
0.07
1.0
1.0
—
—
—
0
0
22
234
0.94
0.06
1.3
1.3
1.12
0.83
nmol/l
0.93
14
191
9
100
0.90
0.06
1.0
1.0
—
—
—
0
0
12
110
1.09
0.05
1.7
1.9
3.90
4.79
mg/l
0.61
12
105
15
140
1.07
0.04
1.6
1.5
—
—
—
0
0
29
302
0.96
0.04
1.3
1.8
41.76
44.51
nmol/l
0.31
29
281
33
319
1.04
0.03
1.1
1.0
—
—
—
0
0
36
351
1.03
0.02
1.1
1.2
—
—
—
0
0
24
232
1.04
0.02
1.8
1.8
—
—
—
0
0
29
282
1.03
0.02
1.1
1.2
—
—
—
0
0
43
438
0.98
0.01
4.8
4.0
4.00
3.99
mmol/l
0.07
43
431
22
214
1.03
0.00
3.7
3.3
58.36
59.03
%
0.07
22
214
23
224
1.03
0.00
1.3
1.6
—
—
—
0
0
31
304
1.02
0.00
1.7
1.7
12872.52
20580.51
e6/l
0.77
21
220
28
282
0.99
0.00
3.3
1.6
—
—
—
0
0
12
119
1.01
0.00
1.3
1.2
14.00
6.13
u/ml
—
6
56
12
119
1.01
0.00
1.3
1.2
2.67
3.57
u/ml
—
6
42
13
129
1.01
0.00
1.0
1.0
—
—
—
0
0
28
279
1.00
0.00
1.1
1.2
—
—
—
0
0
96
965
0.99
0.00
1.3
1.8
1.69
1.65
%
0.15
76
791
21
205
1.02
0.00
3.3
3.0
5.21
4.52
e9/l
0.55
21
205
6
62
0.97
0.00
1.0
2.5
—
—
—
0
0
6
62
0.97
0.00
1.3
2.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
3.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
8.0
—
74.80
—
0
5
7
70
1.00
-0.00
1.0
1.1
—
—
—
0
0
5
55
0.91
-0.00
2.2
1.5
0.73
0.93
g/l
—
5
55
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
2.33
—
0
6
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
-0.00
1.0
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
22.63
—
0
8
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
66
0.91
-0.00
1.2
1.1
—
—
—
0
0
5
55
0.91
-0.00
2.6
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
6
63
0.95
-0.00
3.5
2.4
774.00
572.82
e6/l
—
6
55
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
3.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_OTHER_NOS – Carcinoma in situ of other and unspecified sites
GWS hits: 3
This endpoint is excluded from FinRegistry analyses (omitted endpoint).